Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
CADTH
Record ID 32012000671
English
Authors' recommendations:
One study showed that the incidence of groin bleeding was significantly higher in the patients receiving prolonged post-procedural heparin compared with the patients not receiving post-procedural heparin following PCI. No relevant PCI studies on aspirin, clopidogrel, tenecteplase or bivulirudin and no relevant evidence-based guidelines regarding the management of procedure site bleeding complications following PCI were identified.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.cadth.ca/media/pdf/htis/mar-2012/RC0342-PCI-Access%20Site%20Bleeding%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Angioplasty, Balloon, Coronary
- Myocardial Infarction
- Postoperative Hemorrhage
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.